{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T22:38:38Z","timestamp":1725403118557},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,10]]},"DOI":"10.7759\/cureus.30122","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T12:45:09Z","timestamp":1665405909000},"source":"Crossref","is-referenced-by-count":1,"title":["IgA Vasculitis With Adalimumab Therapy for Hidradenitis Suppurativa: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Alsulami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakan M","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal F","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal B","family":"Almatrafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa M","family":"Filmban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sultan","family":"Alneefia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AhmedHusam","family":"Alahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed A","family":"Hafiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette JC","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, et al.. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013, 65:1-11. 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin JMM","year":"2002","unstructured":"Gardner-Medwin JMM, Dolezalova P, Cummins C, Southwood TR. Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet. 2002, 360:1197-1202. 10.1016\/S0140-6736(02)11279-7","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000019","article-title":"Henoch-Sch\u00f6nlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center","volume":"93","author":"Calvo-R\u00edo V","year":"2014","unstructured":"Calvo-R\u00edo V, Loricera J, Mata C, et al.. Henoch-Sch\u00f6nlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center. Medicine (Baltimore). 2014, 93:106-113. 10.1097\/MD.0000000000000019","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000013883.99976.22","article-title":"Henoch-Sch\u00f6nlein purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout E","year":"2002","unstructured":"Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Sch\u00f6nlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol. 2002, 13:1271-1278. 10.1097\/01.asn.0000013883.99976.22","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"22","author":"Lau KK","year":"2007","unstructured":"Lau KK, Wyatt RJ, Moldoveanu Z, et al.. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura. Pediatr Nephrol. 2007, 22:2067-2072. 10.1007\/s00467-007-0623-y","journal-title":"Pediatr Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura)","volume":"16","author":"Heineke MH","year":"2017","unstructured":"Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Sch\u00f6nlein purpura). Autoimmun Rev. 2017, 16:1246-1253. 10.1016\/j.autrev.2017.10.009","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.40178","article-title":"Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: data from 260 patients included in a French multicenter retrospective survey","volume":"69","author":"Audemard-Verger A","year":"2017","unstructured":"Audemard-Verger A, Terrier B, Dechartres A, et al.. Characteristics and management of IgA vasculitis (Henoch-Sch\u00f6nlein) in adults: data from 260 patients included in a French multicenter retrospective survey. Arthritis Rheumatol. 2017, 69:1862-1870. 10.1002\/art.40178","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330809","article-title":"The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch\u00f6nlein purpura","volume":"33","author":"Mills JA","year":"1990","unstructured":"Mills JA, Michel BA, Bloch DA, et al.. The American College of Rheumatology 1990 criteria for the classification of Henoch-Sch\u00f6nlein purpura. Arthritis Rheum. 1990, 33:1114-1121. 10.1002\/art.1780330809","journal-title":"Arthritis Rheum"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa?","volume":"17","author":"Ralf Paus L","year":"2008","unstructured":"Ralf Paus L, Kurzen H, Kurokawa I, et al.. What causes hidradenitis suppurativa?. Exp Dermatol. 2008, 17:455-456. 10.1111\/j.1600-0625.2008.00712_1.x","journal-title":"Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat R","year":"2020","unstructured":"Sabat R, Jemec GB, Matusiak \u0141, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020, 6:18. 10.1038\/s41572-020-0149-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14686","article-title":"A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP)","volume":"32","author":"Delany E","year":"2018","unstructured":"Delany E, Gormley G, Hughes R, et al.. A cross-sectional epidemiological study of hidradenitis suppurativa in an Irish population (SHIP). J Eur Acad Dermatol Venereol. 2018, 32:467-473. 10.1111\/jdv.14686","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey D","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008, 117:244-279. 10.1016\/j.pharmthera.2007.10.001","journal-title":"Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.01.005","article-title":"Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases","volume":"10","author":"Taylor PC","year":"2010","unstructured":"Taylor PC. Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr Opin Pharmacol. 2010, 10:308-315. 10.1016\/j.coph.2010.01.005","journal-title":"Curr Opin Pharmacol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.4","article-title":"Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?","volume":"7","author":"Atzeni F","year":"2015","unstructured":"Atzeni F, Gianturco L, Talotta R, Varisco V, Ditto MC, Turiel M, Sarzi-Puttini P. Investigating the potential side effects of anti-TNF therapy for rheumatoid arthritis: cause for concern?. Immunotherapy. 2015, 7:353-361. 10.2217\/imt.15.4","journal-title":"Immunotherapy"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v1.i5.119","article-title":"Henoch-Sch\u00f6nlein purpura complicating adalimumab therapy for Crohn's disease","volume":"1","author":"Rahman FZ","year":"2010","unstructured":"Rahman FZ, Takhar GK, Roy O, Shepherd A, Bloom SL, McCartney SA. Henoch-Sch\u00f6nlein purpura complicating adalimumab therapy for Crohn's disease. World J Gastrointest Pharmacol Ther. 2010, 1:119-122. 10.4292\/wjgpt.v1.i5.119","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2812980","article-title":"Henoch-Sch\u00f6nlein purpura with adalimumab therapy for ulcerative colitis: a case report and review of the literature","volume":"2016","author":"LaConti JJ","year":"2016","unstructured":"LaConti JJ, Donet JA, Cho-Vega JH, Sussman DA, Ascherman D, Deshpande AR. Henoch-Sch\u00f6nlein purpura with adalimumab therapy for ulcerative colitis: a case report and review of the literature. Case Rep Rheumatol. 2016, 2016:2812980. 10.1155\/2016\/2812980","journal-title":"Case Rep Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X19882852","article-title":"Hidradenitis suppurativa and vasculitis: a case series and literature review of a rare association","volume":"7","author":"Alavi A","year":"2019","unstructured":"Alavi A, Shavit E, Archer J, Pagnoux C. Hidradenitis suppurativa and vasculitis: a case series and literature review of a rare association. SAGE Open Med Case Rep. 2019, 7:2050313X19882852. 10.1177\/2050313X19882852","journal-title":"SAGE Open Med Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118149-iga-vasculitis-with-adalimumab-therapy-for-hidradenitis-suppurativa-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:31Z","timestamp":1707508171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118149-iga-vasculitis-with-adalimumab-therapy-for-hidradenitis-suppurativa-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.30122","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}